08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
There is rightfully a lot of buzz in the industry about force majeure clauses. Authors are writing ...
Read More >
The U. S. Department of the Treasury recently issued final regulations governing hardship distributi...
Read More >
Bricker & Eckler's construction attorneys are proud to present "Top Gun," our premier Midwest constr...
Read More >
The Department of Justice and eleven state Attorneys General filed an antitrust case against Google ...
Read More >
Carroll v. City & Cnty. of S.F., 41 Cal. App. 5th 805, 254 Cal. Rptr. 3d 519 (2019) - Summary: Eac...
Read More >
The US Federal Trade Commission (FTC) yesterday released decreased thresholds for the Hart-Scott-Rod...
Read More >